Tuberculosis
Findings in Tuberculosis Reported from French National Institute of Health and Medical Research (INSERM)
Published in TB and Outbreaks Week, May 29th, 2012
2012 MAY 29 (NewsRx) -- By a News Reporter-Staff News Editor at TB & Outbreaks Week -- Research findings on Tuberculosis are discussed in a new report. According to news reporting from Lille, France, by NewsRx journalists, researchers stated "Ethionamide is an antituberculous drug for the treatment of multidrug-resistant Mycobacterium tuberculosis. This antibiotic requires activation by the monooxygenase EthA to exert its activity."
The news correspondents obtained a quote from the research by the authors from the French National Institute of Health and Medical Research (INSERM), "Production of EthA is controlled by the transcriptional repressor EthR, a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Pandemics
New Pandemics Research from Pusan National University School of Medicine Outlined - Pandemics
Research from European Commission Provides New Data on Pandemics - Tuberculosis
Data from Karolinska University Hospital Provide New Insights into Tuberculosis - Tuberculosis
Data on Tuberculosis Detailed by Researchers at Wuhan University - Tuberculosis
Findings from Colorado State University Broaden Understanding of Tuberculosis - Tuberculosis
Findings from University College London Broaden Understanding of Tuberculosis - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
